As more and more routine plastic surgery procedures move from the hospital to outpatient surgery facilities, plastic surgeons must be aware of the risk factors for life-threatening events that might occur in this setting. This awareness includes recognition of the signs and symptoms and the management of a rare but life-threatening condition, malignant hyperthermia. This article reviews the current understanding of the concepts pertinent to malignant hyperthermia diagnosis and treatment in the outpatient setting and current standards and recommendations for physicians and support personnel regarding malignant hyperthermia preparedness in office-based surgery and anesthesia.
Denver, Colo.; and Arlington Heights, Ill.
From the Denver Health Medical Center and the American Society of Plastic Surgeons’ Patient Safety Committee.
Received for publication March 3, 2009; accepted May 27, 2009.
Approved by the ASPS Executive Committee, January 10, 2009.
The members of the ASPS Patient Safety Committee are listed at the end of this article.
Disclosure: The authors have no commercial associations that might pose or create a conflict of interest with the information presented in this article.
Raffi Gurunluoglu, M.D., Ph.D., 777 Bannock Street, Denver, Colo. 80204, firstname.lastname@example.org